Your browser doesn't support javascript.
loading
Neutralizing Antibody Responses against Five SARS-CoV-2 Variants and T Lymphocyte Change after Vaccine Breakthrough Infections from the SARS-CoV-2 Omicron BA.1 Variant in Tianjin, China: A Prospective Study.
Zhang, Ying; Qu, Jiang Wen; Zheng, Min Na; Ding, Ya Xing; Chen, Wei; Ye, Shao Dong; Li, Xiao Yan; Li, Yan Kun; Liu, Ying; Zhu, Di; Jin, Can Rui; Wang, Lin; Yang, Jin Ye; Zhai, Yu; Wang, Er Qiang; Meng, Xing.
Afiliación
  • Zhang Y; Tianjin Center for Disease Control and Prevention, Tianjin 300011, China.
  • Qu JW; Tianjin Center for Disease Control and Prevention, Tianjin 300011, China.
  • Zheng MN; Tianjin Center for Disease Control and Prevention, Tianjin 300011, China;Tianjin Key Laboratory of Pathogenic Microbiology of Infectious Disease, Tianjin 300011, China.
  • Ding YX; Tianjin Center for Disease Control and Prevention, Tianjin 300011, China.
  • Chen W; Tianjin Center for Disease Control and Prevention, Tianjin 300011, China.
  • Ye SD; National Center for AIDS/STD Control and Prevention, Chinese Center for Disease Control and Prevention, Beijing 102206, China.
  • Li XY; Tianjin Center for Disease Control and Prevention, Tianjin 300011, China;Tianjin Key Laboratory of Pathogenic Microbiology of Infectious Disease, Tianjin 300011, China.
  • Li YK; Tianjin Center for Disease Control and Prevention, Tianjin 300011, China.
  • Liu Y; Tianjin Center for Disease Control and Prevention, Tianjin 300011, China.
  • Zhu D; Tianjin Center for Disease Control and Prevention, Tianjin 300011, China.
  • Jin CR; Sinovac Biotech Ltd, Beijing 100085, China.
  • Wang L; Sinovac Biotech Ltd, Beijing 100085, China.
  • Yang JY; Sinovac Biotech Ltd, Beijing 100085, China.
  • Zhai Y; Sinovac Biotech Ltd, Beijing 100085, China.
  • Wang EQ; Sinovac Biotech Ltd, Beijing 100085, China.
  • Meng X; Sinovac Biotech Ltd, Beijing 100085, China.
Biomed Environ Sci ; 36(7): 614-624, 2023 Jul 20.
Article en En | MEDLINE | ID: mdl-37533385
Asunto(s)
Palabras clave
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Anticuerpos Neutralizantes / COVID-19 Tipo de estudio: Observational_studies / Risk_factors_studies Límite: Humans País/Región como asunto: Asia Idioma: En Revista: Biomed Environ Sci Asunto de la revista: SAUDE AMBIENTAL Año: 2023 Tipo del documento: Article País de afiliación: China Pais de publicación: China
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Anticuerpos Neutralizantes / COVID-19 Tipo de estudio: Observational_studies / Risk_factors_studies Límite: Humans País/Región como asunto: Asia Idioma: En Revista: Biomed Environ Sci Asunto de la revista: SAUDE AMBIENTAL Año: 2023 Tipo del documento: Article País de afiliación: China Pais de publicación: China